Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ranbaxy settles patent litigation with GlaxoSmithKline
The terms of the settlement provide that Ranbaxy may distribute a generic version of sumatriptan succinate tablets (in the 25mg, 50mg and 100mg strengths) in the US with
The terms of the settlement provide that Ranbaxy may distribute a generic version of sumatriptan succinate tablets (in the 25mg, 50mg and 100mg strengths) in the US with
The Intelence approval is based on the 24-week analysis of HIV viral load and CD4+ cell counts from the pooled analysis of the Duet studies. This indication is
The study will determine whether Nerites novel polymer coatings can prevent biofilm growth, the source of most infections on urinary stents and catheters. Biofilms grow on the surface
The acquired industrial complex covers a surface area of 31,000 square meters, of which 6,000 m2 is a parcel of land on which the company plans to build
The BD FACSAria design is based on a true fixed alignment flow cell that is gel-coupled to the collection optics. This unique design is expected to minimize startup
The site, which covers an area of 300,000 square metres, is located in the township of Nerviano, 30km from Milan, and employs around 340 permanent staff. Separately, Actavis
The second milestone payment of the collaboration of DKK87.2 million was triggered by treatment of the first patient in the Phase II study of ofatumumab in diffuse large
Under the terms of the agreement, Dr. Reddy’s will not launch its generic rivastigmine tartrate capsules until sometime before the expiry of the orange book patents claiming rivastigmine.
Bederra issued 15 million restricted common shares of stock for the assets of Diagnosis, which will operate as a wholly owned subsidiary of Bederra. Graham Williams, president of
The soft tissue sarcoma trial was completed and provided evidence of clinical activity. The initial analysis of the results supports continued development of the compound for this indication